Education
About Us
Working with TipRanks
Follow Us
Tomas J. Heyman Insider Profile
4 Followers
Tomas J. Heyman, Director at Akero Therapeutics, holds 0.00 shares in Akero Therapeutics (Ticker: AKRO), holds ― shares in Optinose (Ticker: OPTN), holds ― shares in Invivyd (Ticker: IVVD).
Tomas J. Heyman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tomas J. Heyman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 21, 2023 - Jun 21, 2024
Return:+55.90%
The most profitable trade made by Tomas J. Heyman
Tomas J. Heyman's Trading History
Akero Therapeutics
Jun 21, 2023
Director
Uninformative Buy
651.04K
$0.00
Optinose
―
Director
―
―
Invivyd
―
Director
―
―
Xilio Therapeutics
―
Director
―
―
Exelixis
Jun 04, 2024
Director
Uninformative Buy
―
$1.43M
List of latest transactions for each holding click on a transaction to see Tomas J. Heyman's performance on stock
You May Also Like
Tomas J. Heyman insider profile FAQ
What is the percentage of profitable transactions made by Tomas J. Heyman?
The percentage of profitable transactions made by Tomas J. Heyman is ―.
What is the average return per transaction made by Tomas J. Heyman?
The average return per transaction made by Tomas J. Heyman is ―.
What stocks does Tomas J. Heyman hold?
Tomas J. Heyman holds: AKRO, OPTN, IVVD, XLO, EXEL stocks.
What was Tomas J. Heyman’s latest transaction?
Tomas J. Heyman latest transaction was an Uninformative Buy of $651.04K.
What was Tomas J. Heyman's most profitable transaction?
Tomas J. Heyman’s most profitable transaction was an Informative Sell of AKRO stock on June 21, 2023. The return on the trade was 55.90%.
What is Tomas J. Heyman's role in Akero Therapeutics?
Tomas J. Heyman's role in Akero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.